Failure is Not an Option: Implementing CCM^® from a HF and EP Perspective

Heart Failure is a progressive condition, and medical management strategies for this patient population has evolved over the years. This program will introduce CCM^® therapy, review the action mechanism, and how the treatment works at the myocardial level. The faculty will review the clinical safety data surrounding the therapy as well as the indications for use. Evaluation and screening of patients that continue to be symptomatic from their heart failure indications despite being on guideline-directed medical treatment continue to be a challenge on all levels. Our faculty will discuss screening best practices, from both an electrophysiology and heart failure perspective, and how to establish a baseline for patients while giving them access to CCM^® therapy that they may qualify to undertake.

Learning Objectives:

• Review the functionality of CCM^® therapy and how the device delivers therapy
• Review the indications for CCM^® therapy
• Discuss the current treatment of heart failure and medical therapy available
• Clarify assessment questions that could be used during a patient evaluation

MODERATOR

FACULTY PANEL